#148 - Why HR Leaders Should Care About 340B

🎙️ New Episode: The Battle Over 340B Drug Pricing – Part 3
If you care about healthcare advocacy, pharmacy savings, and the sustainability of your hospital, this episode of The ASHHRA Podcast is a must-listen.

In the studio:
Your co-host Bo Brabo is joined again by two returning experts—Sarah Hearn of RxBenefits and Rhiannon Klein, a frontline 340B advocate—for a compelling update on where things stand with the 340B drug pricing program.

In this episode, you’ll learn:
💊 340B Basics Made Clear – Rhiannon breaks down what 340B is, why it exists, and how it keeps hospitals and clinics serving vulnerable communities.
🤝 Why HR Should Care – Sarah shares how 340B can dramatically reduce employee drug costs and why HR and pharmacy teams must work together to protect these savings.
⚖️ Current Advocacy Trends – From litigation and state legislation to industry misinformation, learn what’s unfolding behind the scenes—and what’s at stake.
🧠 Fighting Misinformation – Hear how advocates are pushing back against pharma talking points and why HR professionals should be in the loop.
🏥 Strengthening Local Ties – Ideas for building hospital-business partnerships that reinvest 340B savings into employee health and community care.
🤖 AI in Pharmacy – A forward-looking take on how artificial intelligence could shape drug claim management and advocacy work in the future.

Trusted Resources Mentioned:
📌 340B Report – Industry updates & news
📌 Apexus 340B University – Free education tools
📌 NACHC – National Association of Community Health Centers

The Big Picture:
340B isn’t just about pharmacy operations—it’s mission-critical for workforce health, HR strategy, and the financial viability of hospitals. Whether you’re in HR, operations, or advocacy, understanding 340B is essential to leading in today’s healthcare environment.

🎧 Listen now to gain the insight and tools needed to protect this vital program—and support the communities who rely on it.

📍 Haven’t heard Parts 1 and 2?
Check out episodes 133 and 135 for a deeper dive into the legislative landscape and why 340B is under fire.